Dr Reddy's Labs

DRREDDY05 Mar 2024
Pharmaceuticals
-12.85 (-0.20%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Dr Reddy's Labs
Dr Reddy's Labs
Pharmaceuticals
DRREDDY05 Mar 2024
-12.85 (-0.20%)
1D
1M
6M
1Y
5Y
All

Dr Reddy's Labs - Share Price & Details

Lowest Today
6291
Highest Today
6338
Today’s Open
6306.95
Prev. Close
6335.95
52 Week High
6505.5
52 Week Low
4310
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
36.02%
Upper Circuit
Lower Circuit
P/E TTM
26.56
P/B Ratio
4.65
Traded Value(Cr)
0.01
EPS TTM
238.57
Book value
Dividend
0.63%

Price Performance

0.00 %
1 Wk
0.00 %
1 M
6.83 %
3 M
36.02 %
1 Y
8.88 %
YTD

Traded Volume Movement

Technical Details

Support 3
6244
Support 2
6268
Support 1
6295
Pivot Point :
6319
Resistance 1
6346
Resistance 2
6370
Resistance 3
6396

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Dr Reddys Laboratories Ltd
₹6,323.10(-12.85/-0.20%)
6,323.10-12.85105,691.9836.0226.564.65
Bliss GVS Pharma Ltd
₹120.10(-2.50/-2.04%)
120.10-2.501,283.5168.8518.801.31
Astrazeneca Pharma India Ltd
₹5,391.40(-62.40/-1.14%)
5,391.40-62.4013,634.5068.6385.4820.82
Cipla Ltd
₹1,472.80(+1.55/0.11%)
1,472.80+1.55118,782.7765.0336.124.59
Abbott India Ltd
₹27,578.85(-14.60/-0.05%)
27,578.85-14.6058,636.0824.0951.1818.86
Amrutanjan Health Care Ltd
₹666.00(+0.20/0.03%)
666.00+0.201,946.187.6044.217.43

About Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 105691.98 crores. It has reported a sales of Rs. 4083.1 crores and a net profit of Rs. 475.2 crores for the quarter ended December 2018. The company management includes K Satish Reddy, G V Prasad,K Satish Reddy,Kalpana Morparia,Shikha Sanjaya Sharma,Leo Puri,K P Krishnan,Pennv Wan,K Randhir Singh,Arun M. Kumar,Claudio Albrecht (Dr Reddys Laboratories Ltd) among others.
Chairman
K Satish Reddy
Registered office
8-2-337 Road No 3,Banjara Hills,Hyderabad,Telangana,500034
FAX :91-40-49002999
Background
Incorporation Year1984
Face Value₹5
Market Lot1

Latest News

Buy or sell: Vaishali Parekh recommends three stocks to buy today
Buy or sell stocks: After showing a sharp upside breakout on 1st March 2024, the Indian stock market continued with the choppy movement for the second consecutive session on Monday. However, key benchmark indices of Dalal Street managed to end higher in the first session of this week. The Nifty 50 index climbed to an all-time high of 22,440 and ended 27 points higher at 22,405 level.
05 Mar 2024 | 09:59 AM
Hot Stocks | JK Lakshmi Cement, Motherson Sumi Wiring, JTEKT India & more
March 2024 began with the Nifty reaching a fresh record high of 22,440. The index found support on the upward sloping trendline adjoining the swing lows of January 24 and February 14 and broke out from the ascending triangle pattern on the weekly chart, indicating continuation of an uptrend. The Nifty has been forming higher tops and higher bottoms on the monthly charts.
05 Mar 2024 | 09:42 AM
Trade Spotlight | How to trade in Piramal Enterprises, BHEL, KEI Industries
The Nifty is likely to face an immediate hurdle at 22,500 in the coming session, given its sustained upward sloping resistance trendline adjoining previous record highs and continuation of higher-highs, higher-lows, but with some volatility and consolidation considering the formation of a Doji candlestick pattern at the top in the previous session. Immediate support is placed at the 22,200 level.
05 Mar 2024 | 09:34 AM
Stocks to Watch | 3 counters which are showing positive derivative set-up.
The Nifty, which hit a new high on March 4 again and ended the session in the green, is trading in positive territory. According to JM Financial, the benchmark index will on March 5 likely face resistance is at 22,450 and if manages to go past it, the index can test 22,600. Intraday support is at 22,350. For March, JM Financial analysts have identified three stocks  which have a robust derivative.
05 Mar 2024 | 09:27 AM
Stocks to Watch | 3 counters which are showing positive derivative set-up
The Nifty, which hit a new high on March 4 again and ended the session in the green, is trading in positive territory. According to JM Financial, the benchmark index will on March 5 likely face resistance is at 22,450 and if manages to go past it, the index can test 22,600. Intraday support is at 22,350. For March, JM Financial analysts have identified three stocks  which have a robust derivative.
05 Mar 2024 | 09:27 AM

Is Dr Reddy's Labs an effective investment?

As on 7th April, Dr Reddy’s Lab stock price has risen by 31.15% over the past 3 years. Investing in stocks, like any other capital investment, involves a certain amount of risk. To mitigate the risks, it's important to research, get professionals' help, and keep up-to-date with market trends.

What is the EPS of Dr Reddy's Labs shares?

For the quarter of Dec 2022, the EPS of Dr Reddy’s Labs was Rs. 74.7/ Share.

Who are the major stockholders of Dr Reddy's Labs shares?

The major stockholders of Dr Reddy’s Labs are: APS Trust Life Insurance Corporation of India J P Morgan Chase Bank Reddy Satish Kallam Family

What is the ROI of Dr Reddy's Labs shares?

As on 7th April, Dr Reddy’s Labs has given an ROI of 8.53% over the past 12 months.

What are the primary indicators used to evaluate Dr Reddy's Labs?

There are several key parameters that investors may consider when evaluating whether to invest in Dr Reddy's Laboratories Ltd. : Financial performance Market position Management quality Valuation Regulatory compliance

How has the profitability of Dr Reddy's Labs Limited evolved over time?

Dr Reddy’s total standalone revenues have steadily grown over the past five years from Rs. 9563.3 crores in March 2018 to Rs. 14887.2 crores in March 2022. And the net profit increased from Rs. 566.9 crores to Rs. 1623.2 crores for the same period.
Click here to see your activities